Conservative Treatment of Patients with Neurogenic Bladder

Wyndaele JJ, Castro D, Madersbacher H, et al. Neurologic urinary and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. Edition. Chapter 17, Committee 12. Health Publications; 2005. p. 1059–162. Murnaghan, 1961, Neurologic disorders of the bladder in Parkinsonism, Br J Urol, 33, 403, 10.1111/j.1464-410X.1961.tb11636.x Litwiller, 1999, Multiple sclerosis and the urologist, J Urol, 161, 743, 10.1016/S0022-5347(01)61760-9 Hampel, 2003, Diabetes mellitus and bladder function. What should be considered, Urologe, 42, 1556, 10.1007/s00120-003-0456-7 Seski, 1977, Bladder dysfunction after radical abdominal hysterectomy, Am J Obstet Gynecol, 128, 643, 10.1016/0002-9378(77)90211-3 Linsenmeyer, 2002, Impact of alpha1-blockers in men with spinal cord injury and upper tract stasis, J Spinal Cord Med, 25, 124, 10.1080/10790268.2002.11753612 Hadley, 1986, Bladder training and related therapies for urinary incontinence in older people, JAMA, 256, 372, 10.1001/jama.256.3.372 Dowd, 2000, Using cognitive startegies to enhance bladder control and comfort, Holist Nurs Pract, 14, 91, 10.1097/00004650-200001000-00013 Wyndaele, 2007, Editorial comment on: a novel product for intermittent catheterisation: its impact on compliance with daily life—international multicentre study, Eur Urol, 52, 220 Dromerick, 2003, Relation of postvoid residual to urinary tract infection during stroke rehabilitation, Arch Phys Med Rehabil, 84, 1369, 10.1016/S0003-9993(03)00201-6 Wyndaele, 2002, Intermittent catheterization: which is the optimal technique?, Spinal Cord, 40, 432, 10.1038/sj.sc.3101312 Chen, 2001, Bladder stone incidence in persons with spinal cord injury: determinants and trends, 1973–1996, Urology, 58, 665, 10.1016/S0090-4295(01)01374-7 Wyndaele, 1990, Clean intermittent self-catheterization: a 12-year followup, J Urol, 143, 906, 10.1016/S0022-5347(17)40132-7 Ku, 2006, Influence of bladder management on epididymo-orchitis in patients with spinal cord injury: clean intermittent catheterization is a risk factor for epididymo-orchitis, Spinal Cord, 44, 165, 10.1038/sj.sc.3101825 Lindehall, 2007, Complications of clean intermittent catheterization in young females with myelomeningocele: 10 to 19 years of followup, J Urol, 178, 1053, 10.1016/j.juro.2007.05.071 Canon, 2007, Nocturnal bladder emptying for reversing urinary tract deterioration due to neurogenic bladder, Curr Urol Rep, 8, 60, 10.1007/s11934-007-0022-8 Turi, 2006, Proportion of complications in patients practicing clean intermittent self-catheterization (CISC) vs indwelling catheter, J Pak Med Assoc, 56, 401 Biering-Sorensen, 2002, Urinary tract infection in individuals with spinal cord lesion, Curr Opin Urol, 12, 45, 10.1097/00042307-200201000-00009 Pannek, 2002, Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy?, Urology, 59, 240, 10.1016/S0090-4295(01)01495-9 Hamid, 2003, Screening cystoscopy and biopsy in patients with neurologic bladder and chronic suprapubic indwelling catheters: is it valid?, J Urol, 170, 425, 10.1097/01.ju.0000076700.00853.ad Linsenmeyer, 2006, Accuracy of predicting bladder stones based on catheter encrustation in individuals with spinal cord injury, J Spinal Cord Med, 29, 402, 10.1080/10790268.2006.11753889 Burns, 1984, Prevention of urinary catheter incrustations by acetohydroxamic acid, J Urol, 132, 455, 10.1016/S0022-5347(17)49689-3 Morris, 2001, Does drinking cranberry juice produce urine inhibitory to the development of crystalline, catheter-blocking Proteus mirabilis biofilms?, BJU Int, 88, 192, 10.1046/j.1464-410x.2001.02248.x Sabbuba, 2005, Does the valve regulated release of urine from the bladder decrease encrustation and blockage of indwelling catheters by crystalline proteus mirabilis biofilms?, J Urol, 173, 262, 10.1097/01.ju.0000141139.76350.49 Jones, 2005, A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan, Eur Urol, 48, 838, 10.1016/j.eururo.2005.07.004 Morris, 1997, Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms?, Br J Urol, 80, 58, 10.1046/j.1464-410X.1997.00185.x Biering-Sorensen, 2001, Urinary tract infections in patients with spinal cord lesions: treatment and prevention, Drugs, 61, 1275, 10.2165/00003495-200161090-00004 Siroky, 2002, Pathogenesis of bacteriuria and infection in the spinal cord injured patient, Am J Med, 113, 67S, 10.1016/S0002-9343(02)01061-6 Madersbacher, 2002, Conservative management in neuropathic urinary incontinence, 697 O’Leary, 2003, Effect of controlled-release oxybutynin on neurologic bladder function in spinal cord injury, J Spinal Cord Med, 26, 159, 10.1080/10790268.2003.11753678 Lehtoranta, 2002, Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity, Scand J Urol Nephrol, 36, 18, 10.1080/003655902317259319 Ferrara, 2001, Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida, BJU Int, 87, 674, 10.1046/j.1464-410x.2001.02152.x Di Stasi, 2001, Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens, J Urol, 165, 491, 10.1097/00005392-200102000-00032 Radziszewski, 2002, Therapeutic effects of intrarectal administration of oxybutynin, Wiad Lek., 55, 691 Madersbacher, 2001, Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurologic and neurologic), World J Urol, 19, 324, 10.1007/s003450100223 Frohlich, 2002, Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20mg trospium chloride twice daily, Int J Clin Pharmacol Ther, 40, 295, 10.5414/CPP40295 Horstmann, 2006, Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage, Neurourol Urodyn, 25, 441, 10.1002/nau.20289 Kitisomprayoonkul, 2000, The efficacy of oxyphencyclimine hydrochloride in treatment of urinary incontinence in spinal cord injured patients with detrusor sphincter dyssynergia, J Thai Rehabil, 10, 23 Andersson, 1988, Current concepts in treatment of disorders of micturition, Drugs, 35, 477, 10.2165/00003495-198835040-00006 Chancellor, 1999, Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder, J Urol, 162, 3, 10.1097/00005392-199907000-00002 Lazzeri, 2004, Intravesical vanilloids and neurogenic incontinence: ten years experience, Urol Int, 72, 145, 10.1159/000075969 Kim, 2003, Chancellor MB Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial, J Spinal Cord Med, 26, 358, 10.1080/10790268.2003.11753706 de Sèze, 2006, Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study, Neurourol Urodyn, 25, 752, 10.1002/nau.20296 Apostolidis, 2006, Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity, Eur Urol, 49, 644, 10.1016/j.eururo.2005.12.010 Haferkamp, 2004, Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder, Eur Urol, 46, 784, 10.1016/j.eururo.2004.07.011 Reitz, 2004, European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurologic detrusor overactivity, Eur Urol, 45, 510, 10.1016/j.eururo.2003.12.004 Kuo, 2003, Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity, Urology, 61, 550, 10.1016/S0090-4295(02)02541-4 de Seze, 2002, Botulinum A toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease, Eur Urol, 42, 56, 10.1016/S0302-2838(02)00209-9 Schurch, 2006, Botulinum toxin for the management of bladder dysfunction, Drugs, 66, 1301, 10.2165/00003495-200666100-00001 Dykstra, 1990, Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study, Arch Phys Med Rehabil, 71, 24 Wyndaele, 2002, Muscular weakness as side effect of botulinum toxin injection for neurologic detrusor overactivity, Spinal Cord, 40, 599, 10.1038/sj.sc.3101318 Hirst, 2007, Botulinum toxin B is not an effective treatment of refractory overactive bladder, Urology, 69, 69, 10.1016/j.urology.2006.09.005 Fader, 2007, Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial, J Urol, 177, 208, 10.1016/j.juro.2006.08.099 Lazzeri, 2006, Daily intravesical instillation of 1mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity: a multicenter, placebo controlled, randomized exploratory study, J Urol, 176, 2098, 10.1016/j.juro.2006.07.025 Abrams, 2003, Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury, J Urol, 170, 1242, 10.1097/01.ju.0000084623.65480.f8 Lewis, 2007, Non-traditional management of the neurogenic bladder: tissue engineering and neuromodulation, ScientificWorldJournal, 7, 1230, 10.1100/tsw.2007.178 Dalmose, 2003, Conditional stimulation of the dorsal penile/clitoral nerve may increase cystometric capacity in patients with spinal cord injury, Neurourol Urodyn, 22, 130, 10.1002/nau.10031 Lee, 2002, Self-controlled dorsal penile nerve stimulation to inhibit bladder hyperreflexia in incomplete spinal cord injury: a case report, Arch Phys Med Rehabil, 83, 273, 10.1053/apmr.2002.28817 Keppene, 2007, Neuromodulation in the management of neurogenic lower urinary tract dysfunction, Prog Urol, 17, 609, 10.1016/S1166-7087(07)92376-3 Roth, 2007, Sacral neuromodulation and lower urinary tract dysfunction in cerebral palsy, Int Urogynecol J Pelvic Floor Dysfunct, 18, 567, 10.1007/s00192-006-0152-4 Krivoborodov, 2006, Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease, Urologiia, 3 Ishigooka, 1993, Electrical pelvic floor stimulation in the management of urinary incontinence due to neuropathic overactive bladder, Front Med Biol Eng, 5, 1 McClurg, 2008, Neuromuscular electrical stimulation and the treatment of lower urinary tract dysfunction in multiple sclerosis–a double blind, placebo controlled, randomised clinical trial, Neurourol Urodyn, 27, 231, 10.1002/nau.20486 Ebner, 1992, Intravesical electrical stimulation-An experimental analysis of the mechanism of action, J Urol, 148, 920, 10.1016/S0022-5347(17)36778-2 Buyle, 1998, Optimal parameters for transurethral intravesical electrostimulation determined in an experiment in the rat, Eur Urol, 33, 507, 10.1159/000019645 Madersbacher, 1990, Intravesical electrical stimulation for the rehabilitation of the neuropathic bladder, Paraplegia, 28, 349, 10.1038/sc.1990.47